Mohammad Yahya Vahidi Mehrjardi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mohammad Yahya Vahidi Mehrjardi has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
Farimah Shamsi
Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4 shared publicationsGhafour Yarahmadi
Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4 shared publicationsMehran Dehghanian
Department of Medical Genetics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4 shared publicationsReyhaneh Sadat Sandoghsaz
Abortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4 shared publications- Masoud Dehghan Tezerjani
Abortion Research Centre, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Science, Yazd, Iran
3 shared publications Zahra Metanat
Department of Genetics, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
3 shared publications
Latest Publications
- 10 June 2025
- Published by Wiley in Genes to Cells
- Vol. 30 (4) , e70032
Microenvironment‐Dependent MSC Immunoregulation in Type 1 Diabetes: Insights From IFNγ Preconditioning
Interferon‐gamma (IFNγ) plays a crucial role in the pathogenesis of type 1 diabetes (T1D) and is widely utilized to license mesenchymal stem/stromal cells (MSCs) to enhance their immunosuppressive properties through a process known as preconditioning or priming. This study investigates the interaction of MSCs preconditioned with (IFNγ+) or without (IFNγ−) IFNγ, with peripheral blood mononuclear cells (PBMCs) from healthy controls (HC) and T1D patients. We assessed the effects of these interactions on anti‐inflammatory gene expression, chemokine and receptor profiles, and the induction of regulatory T (Treg) cells. Our findings reveal contrasting responses in HC and T1D PBMCs when exposed to IFNγ+ and IFNγ− MSCs, particularly in the expression of key genes such as CXCR3 and its ligands (CXCL9, CXCL10), CXCR6, CCR5, and its ligands (CCL3 and CCL4). Pathway enrichment analysis further showed that IFNγ preconditioning tailors MSC responses to specific immune microenvironments. These differential gene expression patterns were also reflected in the proportions of Treg cells, which varied depending on whether paracrine signaling or direct cell contact was involved. Collectively, our results demonstrate that IFNγ+ and IFNγ− MSCs create distinct immunomodulatory microenvironments in T1D PBMCs compared to HC PBMCs, emphasizing the potential for tailored MSC‐based therapies in T1D treatment.
- 10 June 2025
- Published by Wiley in Genes to Cells
- Vol. 30 (4) , e70032
Microenvironment‐Dependent MSC Immunoregulation in Type 1 Diabetes: Insights From IFNγ Preconditioning
Interferon‐gamma (IFNγ) plays a crucial role in the pathogenesis of type 1 diabetes (T1D) and is widely utilized to license mesenchymal stem/stromal cells (MSCs) to enhance their immunosuppressive properties through a process known as preconditioning or priming. This study investigates the interaction of MSCs preconditioned with (IFNγ+) or without (IFNγ−) IFNγ, with peripheral blood mononuclear cells (PBMCs) from healthy controls (HC) and T1D patients. We assessed the effects of these interactions on anti‐inflammatory gene expression, chemokine and receptor profiles, and the induction of regulatory T (Treg) cells. Our findings reveal contrasting responses in HC and T1D PBMCs when exposed to IFNγ+ and IFNγ− MSCs, particularly in the expression of key genes such as CXCR3 and its ligands (CXCL9, CXCL10), CXCR6, CCR5, and its ligands (CCL3 and CCL4). Pathway enrichment analysis further showed that IFNγ preconditioning tailors MSC responses to specific immune microenvironments. These differential gene expression patterns were also reflected in the proportions of Treg cells, which varied depending on whether paracrine signaling or direct cell contact was involved. Collectively, our results demonstrate that IFNγ+ and IFNγ− MSCs create distinct immunomodulatory microenvironments in T1D PBMCs compared to HC PBMCs, emphasizing the potential for tailored MSC‐based therapies in T1D treatment.
- Open Access
- 20 March 2025
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 26 (1)
Investigation of rs328 polymorphism of lipoprotein lipase and rs1260326 polymorphism of glucokinase regulatory genes in individuals with type 2 diabetes in Yazd, Iran
Background: Type 2 diabetes (T2DM) is a complex disease influenced by both genetic and environmental factors, affecting significant percentage of the global population. Early detection through biomarkers is crucial for preventing future complications. The lipoprotein lipase (LPL) gene, involved in lipid metabolism, and the glucokinase regulatory gene (GCKR), regulating glucose metabolism, both play roles in T2DM. The purpose of this study was to determine the prevalence of the GCKR rs1260326 and LPL rs328 polymorphisms, in Yazd Province's familial T2DM population. Results: Since January 2024, from the patients referred to the Yazd Province Diabetes Research Center, 150 type 2 diabetes samples were collected for this case–control study. Informed written agreement was obtained from the participants once they were informed about the study's specifics, and 150 samples were also taken from the referring individuals who were healthy controls. Double-tube ARMS-PCR method was used to identify the presence or absence of the target polymorphisms. The genotypic frequencies of the rs328 and rs1260326 polymorphisms differed significantly between the patient and control groups (p = 0.001 and p = 0.0342, respectively). Both SNPs showed the highest significance (p = 0.000) when nephritis symptoms were present. Conclusions: The results of this study suggest a potential association between type 2 diabetes and the GCKR and LPL polymorphisms (rs1260326 and rs328) in the Yazd province population. However, further research is needed to confirm these findings.
- 20 March 2025
- Published by Springer Nature in Egyptian Journal of Medical Human Genetics
- Vol. 26 (1)
Open AccessInvestigation of rs328 polymorphism of lipoprotein lipase and rs1260326 polymorphism of glucokinase regulatory genes in individuals with type 2 diabetes in Yazd, Iran
Background: Type 2 diabetes (T2DM) is a complex disease influenced by both genetic and environmental factors, affecting significant percentage of the global population. Early detection through biomarkers is crucial for preventing future complications. The lipoprotein lipase (LPL) gene, involved in lipid metabolism, and the glucokinase regulatory gene (GCKR), regulating glucose metabolism, both play roles in T2DM. The purpose of this study was to determine the prevalence of the GCKR rs1260326 and LPL rs328 polymorphisms, in Yazd Province's familial T2DM population. Results: Since January 2024, from the patients referred to the Yazd Province Diabetes Research Center, 150 type 2 diabetes samples were collected for this case–control study. Informed written agreement was obtained from the participants once they were informed about the study's specifics, and 150 samples were also taken from the referring individuals who were healthy controls. Double-tube ARMS-PCR method was used to identify the presence or absence of the target polymorphisms. The genotypic frequencies of the rs328 and rs1260326 polymorphisms differed significantly between the patient and control groups (p = 0.001 and p = 0.0342, respectively). Both SNPs showed the highest significance (p = 0.000) when nephritis symptoms were present. Conclusions: The results of this study suggest a potential association between type 2 diabetes and the GCKR and LPL polymorphisms (rs1260326 and rs328) in the Yazd province population. However, further research is needed to confirm these findings.
- Open Access
- 7 March 2025
- Published by Springer Nature in npj Genomic Medicine
- Vol. 10 (1) , 1-9
Uncovering the genetic architecture of inherited retinal disease in a consanguineous Iranian cohort
An integrated approach combining whole exome sequencing (WES) and autozygosity mapping was used to molecularly diagnose inherited retinal disease (IRD) in 192 unrelated Iranian families, 76.1% of which originate from a consanguineous background. Data analysis was performed using an in-house pipeline to detect single-nucleotide variants (SNVs), small insertions and deletions, copy number variants (CNVs) and runs of homozygosity (ROHs). Using this approach, we obtained a molecular diagnosis for 72.9% of the cohort. In total, 209 variants were identified in 78 IRD-associated genes. The majority occurred only once (81.8%) and 52.9% were novel. Variants in ROHs were found in 82.8% of patients from consanguineous backgrounds. The importance of structural variation (SV) was demonstrated, with CNVs identified in 5.3%, including several novel CNVs. Multilocus genomic variation was observed in two families. This integrated study using WES and in-depth variant assessment significantly expanded the molecular spectrum of IRD in Iran, an understudied population.
- 7 March 2025
- Published by Springer Nature in npj Genomic Medicine
- Vol. 10 (1) , 1-9
Open AccessUncovering the genetic architecture of inherited retinal disease in a consanguineous Iranian cohort
An integrated approach combining whole exome sequencing (WES) and autozygosity mapping was used to molecularly diagnose inherited retinal disease (IRD) in 192 unrelated Iranian families, 76.1% of which originate from a consanguineous background. Data analysis was performed using an in-house pipeline to detect single-nucleotide variants (SNVs), small insertions and deletions, copy number variants (CNVs) and runs of homozygosity (ROHs). Using this approach, we obtained a molecular diagnosis for 72.9% of the cohort. In total, 209 variants were identified in 78 IRD-associated genes. The majority occurred only once (81.8%) and 52.9% were novel. Variants in ROHs were found in 82.8% of patients from consanguineous backgrounds. The importance of structural variation (SV) was demonstrated, with CNVs identified in 5.3%, including several novel CNVs. Multilocus genomic variation was observed in two families. This integrated study using WES and in-depth variant assessment significantly expanded the molecular spectrum of IRD in Iran, an understudied population.
- Open Access
- 27 January 2025
- Published by Apex Publishing in Neurology Letters
- Vol. 4 (1) , 53-57
From Clinical Presentation to Genetic Confirmation: A Case of L2HGDH-Related Leukodystrophy in an 11-Year-Old
Background: Leukodystrophy describes a diverse range of rare and severe neurological disorders characterized by progressive degeneration of the central nervous system (CNS) and a heterogeneous genetic basis. Leukodystrophies cause a progressive loss of neurological function in infants, children, and sometimes adults. Each type of leukodystrophy is rare and causes different symptoms, such as seizures, balance and mobility problems, behavioral and learning disabilities, developmental delays, hearing, speech, and vision problems.Case Presentation: An 11-year-old female was referred to the Children's Department of Shahid Sadoughi Hospital in Yazd, Iran. She had been diagnosed with leukodystrophy, confirmed by MRI findings and urinary organic acid profiling, indicating abnormalities in the central nervous system (CNS). The disease onset occurred when she was three years old and was initially characterized by seizures, followed by developmental regression. The patient exhibited developmental delay, seizures, encephalopathy, cerebellar ataxia, and other clinical neurological deficits.Methods: In the present study, we ascertained the identity of a patient through clinical studies, including MRI findings and biochemical tests. Whole-exome sequencing (WES) was then conducted to investigate various variants associated with leukodystrophy and determine the specific type present in the patient. The analysis revealed a mutation in L2HGDH (L-2-hydroxyglutarate dehydrogenase), which is associated with a specific type of leukodystrophy. To confirm this, Sanger sequencing was performed on twelve members of the patient's family, all diagnosed with autosomal recessive neurodevelopmental disorders. In silico studies, including protein structural modeling and docking analyses, were conducted using Phyre-2 tools to further investigate the molecular consequences of the mutation in L2HGDH.Result: After the filtration the data obtained from Whole exome sequencing of the patient identified a homozygous missense mutation (c.751C>T; p. Arg251Ter) in L2HGDH gene. Sanger sequencing performed in twelve extended relatives and confirmed the presence of this homozygous variant in one patient and one affected sibling from their respective families. Our computational analysis revealed that this variant is conserved regions observed in various species, and they are likely to impact protein stability.Conclusion: In conclusion, our findings provide evidence supporting the correlation between genotype and MRI findings, as well as the pathogenicity of the identified variant in these patients. This study expands our understanding of potential mutations involved in this heterogeneous disease.
- 27 January 2025
- Published by Apex Publishing in Neurology Letters
- Vol. 4 (1) , 53-57
Open AccessFrom Clinical Presentation to Genetic Confirmation: A Case of L2HGDH-Related Leukodystrophy in an 11-Year-Old
Background: Leukodystrophy describes a diverse range of rare and severe neurological disorders characterized by progressive degeneration of the central nervous system (CNS) and a heterogeneous genetic basis. Leukodystrophies cause a progressive loss of neurological function in infants, children, and sometimes adults. Each type of leukodystrophy is rare and causes different symptoms, such as seizures, balance and mobility problems, behavioral and learning disabilities, developmental delays, hearing, speech, and vision problems.Case Presentation: An 11-year-old female was referred to the Children's Department of Shahid Sadoughi Hospital in Yazd, Iran. She had been diagnosed with leukodystrophy, confirmed by MRI findings and urinary organic acid profiling, indicating abnormalities in the central nervous system (CNS). The disease onset occurred when she was three years old and was initially characterized by seizures, followed by developmental regression. The patient exhibited developmental delay, seizures, encephalopathy, cerebellar ataxia, and other clinical neurological deficits.Methods: In the present study, we ascertained the identity of a patient through clinical studies, including MRI findings and biochemical tests. Whole-exome sequencing (WES) was then conducted to investigate various variants associated with leukodystrophy and determine the specific type present in the patient. The analysis revealed a mutation in L2HGDH (L-2-hydroxyglutarate dehydrogenase), which is associated with a specific type of leukodystrophy. To confirm this, Sanger sequencing was performed on twelve members of the patient's family, all diagnosed with autosomal recessive neurodevelopmental disorders. In silico studies, including protein structural modeling and docking analyses, were conducted using Phyre-2 tools to further investigate the molecular consequences of the mutation in L2HGDH.Result: After the filtration the data obtained from Whole exome sequencing of the patient identified a homozygous missense mutation (c.751C>T; p. Arg251Ter) in L2HGDH gene. Sanger sequencing performed in twelve extended relatives and confirmed the presence of this homozygous variant in one patient and one affected sibling from their respective families. Our computational analysis revealed that this variant is conserved regions observed in various species, and they are likely to impact protein stability.Conclusion: In conclusion, our findings provide evidence supporting the correlation between genotype and MRI findings, as well as the pathogenicity of the identified variant in these patients. This study expands our understanding of potential mutations involved in this heterogeneous disease.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1)
Genetic Characterization of MODY in Iranian Families Using Multigenerational‐Based Whole‐Exome Sequencing Approach
Background: Maturity‐onset diabetes of the young (MODY), a common type of monogenic diabetes caused by a pathogenic variant in a single gene, is characterized by starting at an early age, autosomal dominant inheritance, and decreased secretion of insulin. Despite its clinical importance, its accurate diagnosis is challenging, and it is often misdiagnosed as other types of diabetes. Therefore, understanding the genetic basis of MODY can improve diagnostic accuracy. Methods: We initially performed genetic counseling for 2964 probands who visited the Yazd Diabetes Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, between 2018 and 2022. Clinical assessments and pedigree analyses were conducted for the accurate clinical diagnosis and management of diabetes. Among these, 11 probands with unknown types of diabetes who met specific criteria, including an inheritance pattern across at least three generations, at least seven affected individuals, and probands being under age 55, were selected for whole‐exome sequencing (WES). Finally, variants were verified by Sanger sequencing, pedigree analysis, and segregation analysis. Results: WES analysis detected pathogenic variants in two families, which confirmed MODY. Family 202 had a novel missense variant (GCK: c.484G > C; p.Gly162Arg; NM_000162.5). In Family 105, an extremely rare pathogenic frameshift variant (HNF1A: c.1136_1137del; p.Pro379ArgfsTer39; NM_000545.8) was identified. The segregation analyses of these variants also revealed that the variants largely co‐segregated with the diabetes phenotype in their respective families. Conclusion: This study clearly demonstrates the effectiveness of WES for the accurate identification of MODY subtypes in Iranian families. Moreover, these findings emphasize the need for further genetic screening programs in Iran to enhance MODY diagnosis, personalized treatment, and family genetic counseling.
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1)
Open AccessGenetic Characterization of MODY in Iranian Families Using Multigenerational‐Based Whole‐Exome Sequencing Approach
Background: Maturity‐onset diabetes of the young (MODY), a common type of monogenic diabetes caused by a pathogenic variant in a single gene, is characterized by starting at an early age, autosomal dominant inheritance, and decreased secretion of insulin. Despite its clinical importance, its accurate diagnosis is challenging, and it is often misdiagnosed as other types of diabetes. Therefore, understanding the genetic basis of MODY can improve diagnostic accuracy. Methods: We initially performed genetic counseling for 2964 probands who visited the Yazd Diabetes Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran, between 2018 and 2022. Clinical assessments and pedigree analyses were conducted for the accurate clinical diagnosis and management of diabetes. Among these, 11 probands with unknown types of diabetes who met specific criteria, including an inheritance pattern across at least three generations, at least seven affected individuals, and probands being under age 55, were selected for whole‐exome sequencing (WES). Finally, variants were verified by Sanger sequencing, pedigree analysis, and segregation analysis. Results: WES analysis detected pathogenic variants in two families, which confirmed MODY. Family 202 had a novel missense variant (GCK: c.484G > C; p.Gly162Arg; NM_000162.5). In Family 105, an extremely rare pathogenic frameshift variant (HNF1A: c.1136_1137del; p.Pro379ArgfsTer39; NM_000545.8) was identified. The segregation analyses of these variants also revealed that the variants largely co‐segregated with the diabetes phenotype in their respective families. Conclusion: This study clearly demonstrates the effectiveness of WES for the accurate identification of MODY subtypes in Iranian families. Moreover, these findings emphasize the need for further genetic screening programs in Iran to enhance MODY diagnosis, personalized treatment, and family genetic counseling.
- 26 February 2024
- Published by Springer Nature in Biochemical Genetics
- Vol. 63 (1) , 22-42
Characterizing Homozygous Variants in Bardet-Biedl Syndrome-Associated Genes Within Iranian Families: Unveiling a Founder Variant in BBS2, c.471G>A
Bardet–Biedl syndrome (BBS) is a rare inherited ciliopathy disorder characterized by a broad spectrum of clinical symptoms such as retinal dystrophy, obesity, polydactyly, genitourinary and kidney anomalies, learning disability, and hypogonadism. The understanding of the variants involved in BBS-causing genes remains incomplete, highlighting the need for further research to develop a molecular diagnostic strategy for this syndrome. Singleton whole-exome sequencing (WES) was performed on sixteen patients. Our study revealed (1) nine patients carried eight homozygous pathogenic variants with four of them being novel (2) Specifically, a synonymous splicing variant (c.471G > A) in BBS2 gene in six patients with Baloch ethnicity. The identification of runs of homozygosity (ROH) calling was performed using the BCFtools/RoH software on WES data of patients harboring c.471G > A variant. The presence of shared homozygous regions containing the identified variant was confirmed in these patients. In-silico analysis predicted the effect of the c.471G > A variants on BBS2 mRNA splicing. This variant results in disrupted wild-type donor site and intron retention in the mature mRNA. (3) And a deletion of exons 14 to 17 in the BBS1 gene was identified in one patient by Copy-Number Variation (CNV) analysis using the ExomeDepth pipeline. Our results identified the founder variant c.471G > A in the BBS2 gene in the Baloch ethnicity of the Iranian population. This finding can guide the diagnostic approach of this syndrome in future studies.
- 26 February 2024
- Published by Springer Nature in Biochemical Genetics
- Vol. 63 (1) , 22-42
Characterizing Homozygous Variants in Bardet-Biedl Syndrome-Associated Genes Within Iranian Families: Unveiling a Founder Variant in BBS2, c.471G>A
Bardet–Biedl syndrome (BBS) is a rare inherited ciliopathy disorder characterized by a broad spectrum of clinical symptoms such as retinal dystrophy, obesity, polydactyly, genitourinary and kidney anomalies, learning disability, and hypogonadism. The understanding of the variants involved in BBS-causing genes remains incomplete, highlighting the need for further research to develop a molecular diagnostic strategy for this syndrome. Singleton whole-exome sequencing (WES) was performed on sixteen patients. Our study revealed (1) nine patients carried eight homozygous pathogenic variants with four of them being novel (2) Specifically, a synonymous splicing variant (c.471G > A) in BBS2 gene in six patients with Baloch ethnicity. The identification of runs of homozygosity (ROH) calling was performed using the BCFtools/RoH software on WES data of patients harboring c.471G > A variant. The presence of shared homozygous regions containing the identified variant was confirmed in these patients. In-silico analysis predicted the effect of the c.471G > A variants on BBS2 mRNA splicing. This variant results in disrupted wild-type donor site and intron retention in the mature mRNA. (3) And a deletion of exons 14 to 17 in the BBS1 gene was identified in one patient by Copy-Number Variation (CNV) analysis using the ExomeDepth pipeline. Our results identified the founder variant c.471G > A in the BBS2 gene in the Baloch ethnicity of the Iranian population. This finding can guide the diagnostic approach of this syndrome in future studies.
- Open Access
- 23 February 2024
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 12 (2) , e2412
Type 1 early infantile epileptic encephalopathy: A case report and literature review
Background: Variants in the Aristaless‐related homeobox (ARX) gene lead to a variety of phenotypes, with intellectual disability being a steady feature. Other features can include severe epilepsy, spasticity, movement disorders, hydranencephaly, and ambiguous genitalia in males. X‐linked Ohtahara syndrome or Type 1 early infantile epileptic encephalopathy (EIEE1) is a severe early‐onset epileptic encephalopathy with arrested psychomotor development caused by hemizygous mutations in the ARX gene, which encodes a transcription factor in fundamental brain developmental processes.Methods: We presented a case report of a 2‐year‐old boy who exhibited symptoms such as microcephaly, seizures, and severe multifocal epileptic abnormalities, and genetic techniques such as autozygosity mapping, Sanger sequencing, and whole‐exome sequencing.Results: We confirmed that the patient had the NM_139058.3:c.84C>A; p.(Cys28Ter) mutation in the ARX gene.Conclusion: The patient with EIEE1 had physical symptoms and hypsarrhythmia on electroencephalogram. Genetic testing identified a causative mutation in the ARX gene, emphasizing the role of genetic testing in EIEE diagnosis.
- 23 February 2024
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 12 (2) , e2412
Open AccessType 1 early infantile epileptic encephalopathy: A case report and literature review
Background: Variants in the Aristaless‐related homeobox (ARX) gene lead to a variety of phenotypes, with intellectual disability being a steady feature. Other features can include severe epilepsy, spasticity, movement disorders, hydranencephaly, and ambiguous genitalia in males. X‐linked Ohtahara syndrome or Type 1 early infantile epileptic encephalopathy (EIEE1) is a severe early‐onset epileptic encephalopathy with arrested psychomotor development caused by hemizygous mutations in the ARX gene, which encodes a transcription factor in fundamental brain developmental processes.Methods: We presented a case report of a 2‐year‐old boy who exhibited symptoms such as microcephaly, seizures, and severe multifocal epileptic abnormalities, and genetic techniques such as autozygosity mapping, Sanger sequencing, and whole‐exome sequencing.Results: We confirmed that the patient had the NM_139058.3:c.84C>A; p.(Cys28Ter) mutation in the ARX gene.Conclusion: The patient with EIEE1 had physical symptoms and hypsarrhythmia on electroencephalogram. Genetic testing identified a causative mutation in the ARX gene, emphasizing the role of genetic testing in EIEE diagnosis.
- Open Access
- 23 September 2023
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 15 (3) , 161-167
Association of NFKB1 gene polymorphism (rs28362491) with cardiometabolic risk factor in patients undergoing coronary angiography
Introduction: Genetic and environmental factors are involved in the pathogenesis of cardiovascular diseases (CVDs). The aim of the study was to investigate between the genotype of the NFKB1 gene and the cardiometabolic risk factor in patients undergoing coronary angiography. Methods: This cross-sectional study was conducted on 462 adults (male and women) aged between 35 and 75 years who referred to Afshar Hospital for coronary angiography in 2021- 2022. The polymerase chain reaction restriction fragment length polymorphism method was used to detect the genotype of rs28362491. Biochemical parameters were measured using commercial kits. Gensini and Syntax scores were calculated using the angiography result to assess the extent of coronary artery stenosis. We used multivariate logistic regression analysis to examine the relationship between genotype variants and cardiometabolic risk factors. Results: There was no association between variant genotypes and abnormally levels of serum alanine aminotransferase (ALT) (P value=0.51), aspartate aminotransferase (AST) (P value=0.99), triglyceride (TG) (P value=0.48), total cholesterol (P value=0.79), low density lipoprotein-cholestero (LDL-C) (P value=0.31), high-density lipoprotein-cholesterol (HDL-C) (P value=0.53), fast blood sugar (FBS) (P value=0.39), systolic blood pressure (P value=0.14), diastolic blood pressure (P value=0.64), Gensini score (P value=0.48) and syntax score (P value=0.74) in the crude model even after adjustment for confounding factors. Conclusion: We found no association between the ATTG polymorphism and cardiometabolic risk factors in patients who had coronary angiography. Further investigations are needed to assess the association between variants of 28362491 and cardiometabolic markers.
- 23 September 2023
- Published by Maad Rayan Publishing Company in Journal of Cardiovascular and Thoracic Research
- Vol. 15 (3) , 161-167
Open AccessAssociation of NFKB1 gene polymorphism (rs28362491) with cardiometabolic risk factor in patients undergoing coronary angiography
Introduction: Genetic and environmental factors are involved in the pathogenesis of cardiovascular diseases (CVDs). The aim of the study was to investigate between the genotype of the NFKB1 gene and the cardiometabolic risk factor in patients undergoing coronary angiography. Methods: This cross-sectional study was conducted on 462 adults (male and women) aged between 35 and 75 years who referred to Afshar Hospital for coronary angiography in 2021- 2022. The polymerase chain reaction restriction fragment length polymorphism method was used to detect the genotype of rs28362491. Biochemical parameters were measured using commercial kits. Gensini and Syntax scores were calculated using the angiography result to assess the extent of coronary artery stenosis. We used multivariate logistic regression analysis to examine the relationship between genotype variants and cardiometabolic risk factors. Results: There was no association between variant genotypes and abnormally levels of serum alanine aminotransferase (ALT) (P value=0.51), aspartate aminotransferase (AST) (P value=0.99), triglyceride (TG) (P value=0.48), total cholesterol (P value=0.79), low density lipoprotein-cholestero (LDL-C) (P value=0.31), high-density lipoprotein-cholesterol (HDL-C) (P value=0.53), fast blood sugar (FBS) (P value=0.39), systolic blood pressure (P value=0.14), diastolic blood pressure (P value=0.64), Gensini score (P value=0.48) and syntax score (P value=0.74) in the crude model even after adjustment for confounding factors. Conclusion: We found no association between the ATTG polymorphism and cardiometabolic risk factors in patients who had coronary angiography. Further investigations are needed to assess the association between variants of 28362491 and cardiometabolic markers.
- Open Access
- 1 April 2023
- Published by Medknow in Advanced Biomedical Research
- Vol. 12 (1) , 101
Evaluation of Rap1GAP and EPAC1 gene expression in endometriosis disease
Background: Endometriosis is a female reproductive system disease in which the endometrial tissue is found in other women's organs. Various factors are effective in the development of endometriosis, and because of the interaction of genetics and environmental factors, this disease is a multi-factorial disease. MAPK/ERK and PI3K/Akt/mTOR pathways are activated by growth factors and steroid hormones and are known as two important pathways involved in the processes of growth, proliferation, and survival of endometriosis cells. Raps, monomeric GTPase of the Ras family, are able to activate these pathways independent of Ras. The goal of our study was to evaluate the expression level of Rap1GAP and EPAC1 genes as two important RapGAPs (GTPase-activating proteins) and RapGEFs (guanine nucleotide exchange factors), respectively, in endometriosis tissues and normal endometrium tissues. Materials and Methods: In this study, 15 samples of women without signs of endometriosis were taken as control samples. Fifteen ectopic and 15 eutopic samples were taken from women with endometriosis using laparoscopic surgery. The expression of EPAC1 and Rap1GAP genes was investigated by the real-time polymerase chain reaction technique, and the results were analyzed by one-way ANOVA test. Results: EPAC1 upregulated significantly in ectopic tissues compared to eutopic and control tissues. Rap1GAP expression was lower in ectopic tissues compared to control and eutopic tissues. Conclusions: Based on these results, it may be concluded that changes in the expression of the Rap1GAP and Epca1 genes may play a role in the pathways involved in the pathogenesis, displacement, and migration of endometriosis cells.
- 1 April 2023
- Published by Medknow in Advanced Biomedical Research
- Vol. 12 (1) , 101
Open AccessEvaluation of Rap1GAP and EPAC1 gene expression in endometriosis disease
Background: Endometriosis is a female reproductive system disease in which the endometrial tissue is found in other women's organs. Various factors are effective in the development of endometriosis, and because of the interaction of genetics and environmental factors, this disease is a multi-factorial disease. MAPK/ERK and PI3K/Akt/mTOR pathways are activated by growth factors and steroid hormones and are known as two important pathways involved in the processes of growth, proliferation, and survival of endometriosis cells. Raps, monomeric GTPase of the Ras family, are able to activate these pathways independent of Ras. The goal of our study was to evaluate the expression level of Rap1GAP and EPAC1 genes as two important RapGAPs (GTPase-activating proteins) and RapGEFs (guanine nucleotide exchange factors), respectively, in endometriosis tissues and normal endometrium tissues. Materials and Methods: In this study, 15 samples of women without signs of endometriosis were taken as control samples. Fifteen ectopic and 15 eutopic samples were taken from women with endometriosis using laparoscopic surgery. The expression of EPAC1 and Rap1GAP genes was investigated by the real-time polymerase chain reaction technique, and the results were analyzed by one-way ANOVA test. Results: EPAC1 upregulated significantly in ectopic tissues compared to eutopic and control tissues. Rap1GAP expression was lower in ectopic tissues compared to control and eutopic tissues. Conclusions: Based on these results, it may be concluded that changes in the expression of the Rap1GAP and Epca1 genes may play a role in the pathways involved in the pathogenesis, displacement, and migration of endometriosis cells.
- Open Access
- 7 December 2022
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
- Vol. 17, 100173
Corrigendum to “Evaluation of NF1 and RASA1 gene expression in endometriosis” [Eur J Obstetr Gynecol Reprod Biol X 15 (2022) 100152]
- 7 December 2022
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology: X
- Vol. 17, 100173
Open AccessCorrigendum to “Evaluation of NF1 and RASA1 gene expression in endometriosis” [Eur J Obstetr Gynecol Reprod Biol X 15 (2022) 100152]